Tecovirimat
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 515 publications
Tecovirimat for the treatment of monkeypox: A review of clinical trials.
Journal: Przeglad epidemiologiczny
Published: April 14, 2026
Lactoferrin blocks orthopoxvirus entry via heparan sulphate and regulates host antiviral pathways.
Journal: Emerging microbes & infections
Published: March 06, 2026
Preparation and powder X-ray diffraction study of tecovirimat hydrate solid forms.
Journal: Acta crystallographica. Section C, Structural chemistry
Published: March 05, 2026
Tecovirimat for the Treatment of Mpox.
Journal: The New England journal of medicine
Published: February 25, 2026
Mpox virus in human breastmilk and tecovirimat pharmacokinetics: implications for postnatal transmission.
Journal: The Lancet. Infectious diseases
Published: January 29, 2026
Assessment of three antiviral compounds against Borealpox virus infection in a mouse model.
Journal: Emerging microbes & infections
Published: January 27, 2026
Mpox therapeutics in the post-STOMP/PALM era.
Journal: Current opinion in HIV and AIDS
Published: January 06, 2026
Removing barriers to tecovirimat treatment for individuals infected with mpox via a novel care delivery model.
Journal: JAAPA : official journal of the American Academy of Physician Assistants
Published: December 23, 2025
Tecovirimat-Related Substance: Characterization, Hirshfeld Analysis, Theoretical Study, In Silico Toxicity Assessment.
Journal: Molecules (Basel, Switzerland)
Published: December 14, 2025
Salinomycin inhibits orthopoxvirus infection in vitro and in vivo by blocking endosomal acidification.
Journal: Antiviral research
Published: December 11, 2025
The evolving mpox threat (2022-2024): clade dynamics, immune evasion, and escalating global health challenges.
Journal: Frontiers in cellular and infection microbiology
Published: December 11, 2025
Last Updated: 04/28/2026